3SBio, Inc. operates as an investment holding company, which engages in the development, production, marketing, and sale of biopharmaceutical products. The company is headquartered in Shenyang, Liaoning and currently employs 6,268 full-time employees. The company went IPO on 2015-06-11. The firm's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The firm is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The firm's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The firm mainly operates its businesses in the domestic and overseas markets.
01530.HK stock price ended at $25 on 화요일, after dropping 0.08%
On the latest trading day Jan 20, 2026, the stock price of 01530.HK fell by 0.08%, dropping from $25.02 to $25.00. During the session, the stock saw a volatility of 1.94%, with prices oscillating between a daily low of $24.80 and a high of $25.28. On the latest trading day, the trading volume for 01530.HK decreased by 23.3M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 6.6M shares were traded, with a market value of approximately $58.9B.
01530.HK 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 2
매도 신호 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
01530.HK은 현재 2개의 매수 신호와 3개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -11.72%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
01530.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 01530.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.